| Fund ID | 805-8480200716 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | Yes |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Iif Int'l Holding Scsp | Other Private | $21.01B |
| Iif US Holding 2 LP | Other Private | $20.76B |
| Iif UK 1 Hedged LP | Other Private | $5.38B |
270 Life Sciences Private Capital Fund I LP reports $220 million in gross assets, among the top 29% of private funds by size.
The stated minimum investment is $100,000.
270 Life Sciences Private Capital Fund I LP is managed by J.P. Morgan Investment Management Inc.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.